Tekcapital Share Discussion Threads

[faz] 16/6/2020 12:35

Why do you all think the FDA meets deadlines?

[ambyth] 16/6/2020 09:26

Scoble2, you should not be disappointed:

As Oldtimer169 posted, after today there will be 10 trading days left of indicated timeline for Belluscura FDA approval, which is due before end of 30th June = "H1".

As per the RNS of 6th May, excerpt below:

"...Belluscura(R) (18.9% ownership) www.belluscura.com

-- Continued progress with its patented portable oxygen concentrator programme
-- Belluscura raised US $2.7m in 2019 at 15p/share to continue with its FDA clearance and go to market strategy equating to a post money valuation of US $9m.

-- Belluscura anticipates receiving 510(K) clearance from the US FDA in H1 2020
-- Post end of period, Belluscura filed an additional patent application covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus. ..."

[ambyth] 16/6/2020 09:24

Yes, that Guident update with market growth rate of 39% per year is certainly appetising

[oldtimer169] 16/6/2020 07:50

Only 2 week left for H1 FDA indicated timeline.Meantimea nice update on Guident.

[scoble2] 16/6/2020 07:25

Disappointed, where is the FDA approval?

[ambyth] 12/6/2020 19:37

Good luck Scoble2

[zooskeeper] 12/6/2020 13:43

Fair play Scoble! I added more at 13.5p. Finger crossed we get the good news soon

[scoble2] 12/6/2020 12:48

My buy order not filled, and filled another order at 13.5p

[ambyth] 12/6/2020 12:43

After midnight there will be only 12 trading days left.....

Belluscura FDA approval due before end of 30th June = "H1", according to RNS of 6th May, excerpt below:

"...Belluscura(R) (18.9% ownership) www.belluscura.com

-- Continued progress with its patented portable oxygen concentrator programme
-- Belluscura raised US $2.7m in 2019 at 15p/share to continue with its FDA clearance and go to market strategy equating to a post money valuation of US $9m.

-- Belluscura anticipates receiving 510(K) clearance from the US FDA in H1 2020
-- Post end of period, Belluscura filed an additional patent application covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus. ..."

[ambyth] 12/6/2020 12:42

scoble2 > touched 13.39p to buy this morning, assume you're still hoping for your order to be fulfilled.

[texaschaser] 04/6/2020 16:17

hahaha pos share

[oldtimer169] 04/6/2020 10:10

That is an interesting link-thanks.The US market is the key focus and where TEK's full potential could be realised.Guident's addressable market is massive.DYOR

[ambyth] 04/6/2020 09:21

£0.925m TEK equity raise completed - good news

[moizz] 03/6/2020 11:30

I make next Wednesday 90 days from 16/3 patent application. Could we have our long awaited news early next week, let's hope so!!

[scoble2] 03/6/2020 10:32

I paced an order @13p if i am lucky and i am watching.

[zooskeeper] 03/6/2020 07:27

Scoble you getting back in this morning?

[daniel81] 02/6/2020 17:39

Should test 17/18p tomorrow be great to test 20p this week.

[scoble2] 02/6/2020 15:34

good luck to you

[zooskeeper] 02/6/2020 15:22

Good luck on that Scoble - could be any time now! Hoping this is the push with little retrace now?! Time will tell....

[scoble2] 02/6/2020 15:06

I am out back soon

[scoble2] 02/6/2020 15:01

if it is due end of this month then I will sell now and get back again in lower price.

[ambyth] 02/6/2020 14:36

Due before end of 30th June = "H1", according to RNS of 6th May, excerpt below:

"...Belluscura(R) (18.9% ownership) www.belluscura.com

-- Continued progress with its patented portable oxygen concentrator programme
-- Belluscura raised US $2.7m in 2019 at 15p/share to continue with its FDA clearance and go to market strategy equating to a post money valuation of US $9m.

-- Belluscura anticipates receiving 510(K) clearance from the US FDA in H1 2020
-- Post end of period, Belluscura filed an additional patent application covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus. ..."

[scoble2] 02/6/2020 12:41

On 10 February 2020, Belluscura has filed an additional patent application (17 patents filed or licensed to-date) entitled "Improved Extracorporeal Membrane Oxygenation Device, System and Related Methods," covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus.

On 16 March 2020, Belluscura plc announced the filing of a patent application on a modular, portable oxygen enrichment ventilation system for treating patients suffering from COPD and ARDS brought on by such diseases as COVID-19.

Until now no further inf requested from FDA so the approval id due anytime.

[thehitman1] 02/6/2020 08:55

please tell, how do you know?.

[arshadte] 02/6/2020 01:23

How do you know ?